2019-present Editorial Board Member of Cancers
2018-present Member of Scientific Advisory Board of the Helmholtz-Zentrum Dresden-Rossendorf Germany
2018-present Member of the UMCG Appointment Advisory Committee for academic promotions
2016-present Editorial Board Member Stem Cells
2016-present Member of the Scientific Council of the European Society of Radiotherapy and Oncology (ESTRO)
2015-2021 Chair of the Radiobiology Committee of ESTRO.
2015-present Editor Biology of Radiotherapy and Oncology, Journal of ESTRO.
2015-2021 Associate senior editor of the International Journal of Radiation Oncology*Biology*Physics.
2014-present Faculty at ESTRO Basic Clinical Radiobiology course
2014-present Chair of the Animal Welfare Body of the University of Groningen, Centre of Life Sciences
2013-present Programme leader of Cancer Research Center Groningen (CRCG) research ; Damage and Repair in Cancer Development and Cancer Treatment (DARE)
2012-present Full Professor of Radiotherapy
EDUCATION
1993-1998 Post-doctoral training in clinical radiation biology. Dept Radiobiology, University of Groningen, The Netherlands
1993 PhD in Molecular Pharmacology, Faculty of Mathematics and Natural Sciences, University of Groningen, The Netherlands
1988 MSc in Biology, University of Groningen
RESEARCH INTERESTS
Radiotherapy is involved in 75% of all cancer treatments. The dose that can be delivered to the tumor however is limited to the tolerance of the surrounding normal tissues. Therefore, the Coppes lab focuses on the effects of radiation on normal tissues in vivo and in vitro organoid models.
177
Scopus Publications
16083
Scholar Citations
61
Scholar h-index
133
Scholar i10-index
Scopus Publications
Radiation-induced interferon-I response impairs thyroid organoid function Rufina Maturi, Davide Cinat, Anne L Jellema-de Bruin, Gabriella De Vita, Schelto Kruijff, Rob P. Coppes, Abel Soto-Gamez Radiotherapy and Oncology, 2026 BACKGROUND AND AIM: Radiotherapy is a standard cancer treatment, but radiation exposure to surrounding healthy tissues may lead to adverse side effects that compromise patient quality of life. In patients with head and neck cancer treated with radiotherapy, thyroid damage is a frequent complication, resulting in hypothyroidism or secondary thyroid malignancies. Although clinically recognized, the molecular mechanisms underlying these side effects remain mostly unexplored. This study aims to characterize the radiation-induced molecular alterations in thyroid organoids. METHODS: Bulk RNA sequencing was performed to investigate transcriptomic changes in tissue-derived thyroid organoids following gamma-irradiation. Observed changes were further validated and explored using qPCRs, western blotting, immunofluorescence, caspase 3/7 activity and organoid forming efficiency. RESULTS: Our findings identify interferon-β signaling as a key mediator of radiation-induced inflammation in the thyroid. Additionally, the intrinsic apoptotic pathway was found to be the predominant mechanism of radiation-induced thyroid cell death. Notably, while IFN-β exhibited a protective effect against apoptosis, it concurrently reduced thyroid stem progenitor cell potential. CONCLUSIONS: These results highlight the dual role of interferon-β signaling in modulating thyroid cell fate after irradiation, potentially promoting survival upon injury at the expense of regenerative potential.
Brain irradiation drives remote liver changes via senescence-independent mechanisms Yuting Jiang, Daniëlle C. Voshart, Alessandro Gustinelli, Ayla C. Scholma, Eline Hageman, Luiza Reali Nazario, Uilke Brouwer, Marco Demaria, Rob P. Coppes, Lara Barazzuol Radiotherapy and Oncology, 2026 BACKGROUND AND PURPOSE: Although radiotherapy is essential for treating brain tumors, it often damages surrounding healthy brain tissue, causing long-term neurocognitive dysfunction. Cellular senescence, a stable state of cell cycle arrest triggered by various stressors including radiation-induced DNA damage, has been implicated in aging- and neurodegeneration-associated cognitive decline via its pro-inflammatory secretome and has been reported to exert paracrine effects on distant organs. However, whether brain irradiation, particularly through the induction of cellular senescence, can trigger changes in peripheral tissues remains largely unknown. MATERIALS AND METHODS: Adult male rats received 14 Gy X-ray irradiation to the brain. Senescence-associated markers were assessed in the brain at 6 and 12 weeks post-irradiation and in peripheral tissues, including the kidney, small intestine, skeletal muscle, and liver, at 17 weeks post-irradiation. Liver samples were further examined for proliferation and fibrosis markers, as well as for liver enzyme activity. The senolytic ABT263 was administered to eliminate senescent cells. RESULTS: Brain irradiation induced senescence-like features in the brain but did not trigger p21-dependent senescence in the tested peripheral tissues. However, brain-irradiated rats exhibited increased proliferation, elevated GFAP levels, and enhanced ALT and AST activity in the liver. These hepatic changes were likely independent of cellular senescence, as they were not reversed by treatment with ABT263. CONCLUSION: Brain irradiation induces liver proliferation, increased GFAP levels, and altered ALT and AST activity, via mechanisms likely independent of senescence. Future investigation of blood GFAP levels is needed to determine whether the enhanced hepatic GFAP levels originate from the brain.
Differential synaptic signaling responses in human cortical organoids after photon and proton irradiation Yuting Jiang, Danieli Born Guerra, Daniëlle C. Voshart, Eline Hageman, Luiza Reali Nazario, Marc-Jan van Goethem, Rob P. Coppes, Lara Barazzuol Stem Cell Reports, 2026 Brain tumors are the most common solid cancer in children, with radiotherapy being a primary treatment. Proton therapy, with its precise dose distribution, is increasingly being used in these patients to minimize damage to the developing brain. However, the biological effects of proton irradiation on the human brain remain unclear. To investigate this, human cortical organoids were exposed to conventional photons, plateau protons, and spread-out Bragg peak (SOBP) protons, followed by comparative transcriptomic profiling. While photons and protons induced similar transcriptional profiles characterized by apoptosis and downregulation of DNA replication, SOBP protons uniquely downregulated genes involved in brain development and synaptic signaling. Functional calcium imaging, cell deconvolution analysis, and immunostaining indicated that SOBP protons impaired neural network function, due to reduced synaptic density and loss in excitatory neuron progenitors. These findings underscore the distinct biological effects of SOBP protons and their potential impact on the developing brain.
Notch signaling is a driver of glandular stem cell activity and regenerative migration after damage Davide Cinat, Rufina Maturi, Jeremy P Gunawan, Anne L Jellema-de Bruin, Laura Kracht, Paola Serrano Martinez, Yi Wu, Abel Soto-Gamez, Marc-Jan van Goethem, Inge R Holtman, Sarah Pringle, Lara Barazzuol, Rob P Coppes EMBO Journal, 2026 Organoid models have significantly enhanced our understanding of adult stem cell function, however, uncovering regulatory mechanisms governing rare and often quiescent stem cells in glandular organs remains challenging. Here, we employ an integrative multi-omics approach, combining single-cell RNA sequencing, bulk ATAC and RNA sequencing, to profile the cellular populations and signaling pathways characterizing a mouse salivary gland organoid model across different temporal stages and after radiation-induced damage. Our findings identify Sox9- and Itgb1/Cd44- expressing cells as primitive adult stem/progenitor populations with a critical migratory role in tissue repair. Notch signaling is a key driver of self-renewal and migration in response to irradiation. Additionally, scRNA-seq analysis of irradiated salivary gland tissue confirms these findings in an in vivo setting. Extending these findings to murine and patient-derived salivary, mammary and thyroid gland organoids, we reveal the conserved role of Notch signaling in coordinating stem/progenitor cell-mediated regeneration across glandular tissues. These insights position Notch signaling as a central regulator of glandular stem cell-like populations and as a promising therapeutic target for enhancing glandular tissue regeneration following cancer therapies.
lncRNAs: a new generation of targets and biomarkers in thyroid cancer Rufina Maturi, Matteo Esposito, Rob P Coppes, Gabriella De Vita European Thyroid Journal, 2026 Long non-coding RNAs (lncRNAs) are untranslated RNA molecules that regulate gene expression through diverse mechanisms, acting as scaffolds, guides, decoys, or signals. In thyroid cancer, the most prevalent endocrine malignancy, lncRNAs are increasingly recognized as key contributors to tumor development and progression. Elucidating these molecular mechanisms is essential for advancing diagnostic, prognostic, and therapeutic strategies. This review highlights major lncRNAs implicated in thyroid cancer, categorizing them as upregulated/oncogenes or downregulated/tumor suppressors and describing their mechanisms of action and interactions. lncRNAs are typically expressed at low levels and tightly regulated to preserve normal cell behavior. In thyroid cancer, they serve as crucial regulators of oncogenesis, frequently acting as competing endogenous RNAs that influence key signaling pathways. While most studies focus on miRNA sponging, other mechanisms are underexplored. Circulating lncRNAs offer potential for non-invasive diagnostics, and several lncRNAs show promise as therapeutic targets. Thus, continued research into the diverse functions of lncRNAs is vital to fully harness their clinical potential in thyroid cancer.
Hyaluronic Acid-silk Fibroin Hydrogel for Salivary Gland Tissue Engineering Maryam Hajiabbas, Cibele Pelissari, Dorian Parisis, Tobias Putz, Claudia D'Agostino, Mirjam Baanstra, Nasiha M'Rabet, Nargis Bolaky, Françoise Gregoire, Nayana Rodrigues Lé, Julia Stanny, Muhammad Shahnawaz Soyfoo, Jason Perret, Armin Shavandi, Robert P. Coppes, Christine Delporte Advanced Healthcare Materials, 2026 Cell‐material‐based therapies have emerged as a promising avenue within tissue engineering strategies for salivary gland (SG) regeneration. However, replicating the complex architecture and functional properties of SG tissue remains a challenge. In this study, we used an engineered in situ cross‐linked hydrogel designed to recapitulate the biochemical and rheological characteristics of SG, providing a platform for investigating SG cell behavior and organoid differentiation. Among hydrogel formulations, derived from enzymatically cross‐linked blends of tyramine‐conjugated hyaluronic acid (HA‐Tyr) and silk fibroin (SF), a blend of 2.5% HA‐Tyr and 4% SF4 (HA‐Tyr‐SF4) showed rheological properties partially comparable to native submandibular glands (SMG), achieving high cell viability. Comparative analyses of cell‐scaffold interactions in 2D and 3D cultures revealed that cell encapsulation within HA‐Tyr‐SF4 hydrogel enhanced cell‐cell spatial organization. Encapsulated NS‐SV‐AC cells and human SG organoids (hSGOs) exhibited morphogenesis, supported by transcriptomic data indicating upregulation of genes associated with SG development, extracellular matrix remodeling, and epithelial phenotype stabilization. Furthermore, hSGOs grown in HA‐Tyr‐SF4 or matrix (MA) of basement membrane extract (BME) displayed similar transcriptomic profiles. This study establishes HA‐Tyr‐SF4 as a reproducible, biologically active scaffold with substantial potential for SG tissue engineering and regenerative medicine applications.
Development of a National Indication Protocol for Proton Therapy in Patients With Seminoma Testis to Reduce the Risk on Subsequent Primary Cancers Nienke Kuijsters, Peter Sinnige, Pauline A. Bakker, Shafak Al Uwini, Charlotte L. Brouwer, Tom Budiharto, Rob P. Coppes, Maarten Dirkx, Martine Franckena, Steven Habraken, Marianne AA de Jong, Yvonne L.B. Klaver, Johannes A. Langendijk, Ada Oele, Erik Schimmel, Ewoud Schuit, Robert Jan Smeenk, Mirko Unipan, Ben Vanneste, Wilma D. Heemsbergen, Liesbeth J. Boersma International Journal of Radiation Oncology Biology Physics, 2026 PURPOSE: To develop a National Indication Protocol for Proton therapy (PT) (NIPP) for selecting seminoma testis patients (STPs) for PT in the Netherlands, aiming at reducing the risk of subsequent primary cancers (SPCs). METHODS AND MATERIALS: A multidisciplinary workgroup developed criteria for an NIPP based on a systematic literature search. To estimate its potential, PT-photon plan comparisons were constructed for 13 historical patients, after which NIPP version 1 was finalized. First clinical results of NIPP-v1 were evaluated. RESULTS: From cohort studies, it was established that the kidney, pancreas, stomach, and bladder were the main organs at risk contributing to excess SPC risks in STPs treated with radiation therapy. Estimated excess relative risks per 1 Gy increase in mean dose were as follows: kidney, 0.13; pancreas, 0.12; stomach, 0.47; and bladder, 0.50. Combined with absolute lifetime risks from the Dutch male population (age, 30-79 years), the corresponding lifetime absolute excess risks (AERs) per 1 Gy increase were +0.20%, +0.16%, +0.28%, and +0.65%, respectively. A first exploratory analysis in 13 replanned historical patients showed potential for an NIPP, as the required AER reduction of ≥2% for a grade 4 adverse event was achievable in 11 cases (85%). In a provisional NIPP version 1, criteria were as follows: age ≤50 years; paraortic and/or para-iliac RT; and no life-threatening comorbidity. In NIPP version 2 (approved and implemented), an estimated lifetime AER reduction of ≥2% by PT was required as well. From the first 76 PT patients based on NIPP-v1, 71% would qualify for NIPP-v2 as well. In 39 available PT-photon comparisons, we found an average 3.0% (median, 2.9%; IQR, 2.1%) AER reduction by PT. CONCLUSIONS: We defined an NIPP for the selection of STPs for PT in the Netherlands, aimed to reduce the risk of SPC. According to this NIPP, about 75% of these patients qualify for PT. Further studies are required to allow inclusion of nononcological late effects as selection criteria in the NIPP.
Establishment of salivary tissue-organoid biorepository: characterizing salivary gland stem/progenitor cells and novel differentiation marker PSMA/FOLH1 Syed Mohammed Musheer Aalam, Ana Rita Varela, Aalim Khaderi, Ronsard J. Mondesir, Dong-Gi Mun, Andrew Ding, Isabelle M. A. Lombaert, Rob P. Coppes, Chitra Priya Emperumal, Akhilesh Pandey, Jeffrey R. Janus, Nagarajan Kannan Npj Regenerative Medicine, 2025 The salivary gland (SG) is vital for oral function and overall health through secretion of saliva. However salivary dysfunction due to aging, medications, autoimmune disorders, and cancer treatments poses significant challenges. We established the first diverse and clinically annotated salivary regenerative biobank at Mayo Clinic to study salivary gland stem/progenitor cells (SGSPCs). Optimization of cell isolation and progenitor assays revealed SGSPCs enriched within the CD24/EpCAM/CD49f+ and PSMA- phenotypes of both submandibular and parotid glands, with clonal differentiation assays highlighting heterogeneity. Induction of PSMA/FOLH1 expression was associated with SGSPC differentiation. Using mass spectrometry-based single cell proteomics, we identified 2461 proteins in SGSPC-enriched cells, including co-expressed cytokeratins, expressed in rare salivary ductal basal cells. Additionally, PRDX, a unique class of peroxiredoxin peroxidases enriched in SGSPCs, demonstrated H 2 O 2 -dependent growth, suggesting a role in salivary homeostasis. These findings provide a foundation for SGSPC research and potential regenerative therapies for salivary gland dysfunction.
IFN-I signaling enhances salivary gland stem and progenitor cell activity after irradiation Davide Cinat, Ryan van der Wal, Mirjam Baanstra, Abel Soto-Gamez, Rufina Maturi, Anne L. Jellema-de Bruin, Uilke Brouwer, Marc-Jan van Goethem, Marcel A. T. M. van Vugt, Lara Barazzuol, Rob P. Coppes Science Signaling, 2025 The goal of radiotherapy in cancer treatment is to maximize DNA damage in tumors while minimizing harm to surrounding healthy tissues, especially to stem and progenitor cells essential for tissue regeneration and organ function. Here, we investigated the molecular responses to photon and proton irradiation, two key modalities in head and neck cancer treatment. Multiomics and in vitro analyses revealed that both photon and proton irradiation of mouse salivary gland organoids induced similar early responses, including DNA damage, micronuclei formation, increased amounts of the cytosolic DNA sensor cGAS, and type I interferon (IFN-I) signaling. In addition, both types of radiation induced comparable increases in the release of mitochondrial DNA (mtDNA) into the cytoplasm and stimulated the production of ZBP1, a cytosolic nucleic acid sensor involved in mtDNA recognition. However, proton irradiation resulted in a more pronounced loss of heterochromatin regulators and derepression of transposable elements at later times after irradiation, which was accompanied by increased accumulation of intracellular double-stranded RNA (dsRNA) and an enhanced RIG-I–mediated IFN-I response. Genetic and pharmacological modulation demonstrated its critical role for IFN-I signaling in enhancing salivary gland stem and progenitor cell activity after irradiation in vitro and in vivo. Our findings reveal more pronounced molecular changes after proton irradiation as compared with photon irradiation and uncover a proregenerative role of IFN-I signaling in the salivary gland, suggesting this pathway as a promising therapeutic target to mitigate radiation-induced side effects.
Patient-derived medullary thyroid cancer organoids: a potential model for mechanistic studies on diagnostics and therapy Eline C Jager, Luc H J Sondorp, Rufina Maturi, Inês F Antunes, Bettien M van Hemel, Uilke Brouwer, Liesbeth Jansen, Wouter T Zandee, Adrienne H Brouwers, Thera P Links, Rob P Coppes, Schelto Kruijff European Thyroid Journal, 2025 Objective Medullary thyroid carcinoma (MTC) is a rare neuroendocrine thyroid tumor, with only 30 new patients annually in the Netherlands. PET imaging provides information on distant metastases, after which tyrosine kinase inhibitors (TKIs) may be initiated. The rarity of the disease impedes large controlled trials, and therefore the challenge of selecting the best TKI and PET tracer for individual patients persists. To explore whether an in vitro model could be developed to guide the selection of appropriate PET tracers or TKI therapies in the future, we aimed to establish an MTC organoid model for the first time. Methods Dispersed cells from MTC biopsies were suspended in Matrigel, allowing organoid formation. The self-renewal potential was tested by dissociation and re-plating cells and determining organoid-forming efficiency. MTC-specific gene and protein expression were characterized by qPCR and immunofluorescent staining. Moreover, MTC-organoids (MTOs) were exposed to TKIs and PET tracers in proof-of-principle experiments. Results Ten MTC biopsies were processed and successfully cultured as MTOs. MTC-derived cells showed self-renewal potency for several passages, indicating the presence of putative stem cells. Gene and protein expression of MTC-specific markers in tissue and MTOs, and function measurements showed the production of calcitonin and CEA. Interpretation of the preliminary experiments with TKIs and PET tracers was limited by sample size but demonstrates their future potential. Conclusion We were able to culture MTC organoids that resemble the original tissue in gene expression, protein expression, and functionality. However, international, multi-center studies are required to meet the standards for future clinical applications.
Clinical applications of human organoids Monique M. A. Verstegen, Rob P. Coppes, Anne Beghin, Paolo De Coppi, Mattia F. M. Gerli, Nienke de Graeff, Qiuwei Pan, Yoshimasa Saito, Shaojun Shi, Amir A. Zadpoor, Luc J. W. van der Laan Nature Medicine, 2025
CANCER STEM CELLS IN RADIOTHERAPY Robert P. Coppes, Michael Baumann, Mechthild Krause, Richard P. Hill Basic Clinical Radiobiology Sixth Edition, 2025
PATHOGENESIS OF LATE NORMAL TISSUE EFFECTS Lara Barazzuol, Peter van Luijk, Robert P. Coppes, Albert J. van der Kogel, Wolfgang Dörr Basic Clinical Radiobiology Sixth Edition, 2025
Small Molecule MIF Modulation Enhances Ferroptosis by Impairing DNA Repair Mechanisms Deng Chen, Chunlong Zhao, Jianqiu Zhang, Catharina W. J. Knol, Angelina Osipyan, Nad'a Majerníková, Tingting Chen, Zhangping Xiao, Jeaunice Adriana, Andrew J. Griffith, Abel Soto Gamez, Petra E. van der Wouden, Robert P. Coppes, Amalia M. Dolga, Hidde J. Haisma, Frank J. Dekker Advanced Science, 2024
MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer Madelon J. H. Metman, Pascal K. C. Jonker, Luc H. J. Sondorp, Bettien M. van Hemel, Mark S. Sywak, Anthony J. Gill, Liesbeth Jansen, Paul J. van Diest, Tessa M. van Ginhoven, Clemens W. G. M. Löwik, Anh H. Nguyen, Dominic J. Robinson, Gooitzen M. van Dam, Thera P. Links, Rob P. Coppes, Rudolf S. N. Fehrmann, Schelto Kruijff European Journal of Nuclear Medicine and Molecular Imaging, 2024
Proton therapy induces a local microglial neuroimmune response Daniëlle C. Voshart, Myrthe Klaver, Yuting Jiang, Hilmar R.J. van Weering, Fleur van Buuren-Broek, Gideon P. van der Linden, Davide Cinat, Harry H. Kiewiet, Justin Malimban, Daniel A. Vazquez-Matias, Luiza Reali Nazario, Ayla C. Scholma, Jeffrey Sewdihal, Marc-Jan van Goethem, Peter van Luijk, Rob P. Coppes, Lara Barazzuol Radiotherapy and Oncology, 2024
Radiotherapy induces persistent innate immune reprogramming of microglia into a primed state Daniëlle C. Voshart, Takuya Oshima, Yuting Jiang, Gideon P. van der Linden, Anna P. Ainslie, Luiza Reali Nazario, Fleur van Buuren-Broek, Ayla C. Scholma, Hilmar R.J. van Weering, Nieske Brouwer, Jeffrey Sewdihal, Uilke Brouwer, Rob P. Coppes, Inge R. Holtman, Bart J.L. Eggen, Susanne M. Kooistra, Lara Barazzuol Cell Reports, 2024
Clinical research for global needs of radiation oncology Michael Baumann, Carol Bacchus, Marianne C. Aznar, Rob P. Coppes, Eric Deutsch, Dietmar Georg, Karin Haustermans, Peter Hoskin, Mechthild Krause, Eric F. Lartigau, Anne W.M. Lee, Steffen Löck, Birgitte V. Offersen, David I. Thwaites, Uulke A. van der Heide, Vincenzo Valentini, Jens Overgaard Radiotherapy and Oncology, 2024
Are hybrid conferences the new standard? Michael Baumann, Carol Bacchus, Marianne C. Aznar, Rob P. Coppes, Eric Deutsch, Dietmar Georg, Karin Haustermans, Peter Hoskin, Mechthild Krause, Eric F. Lartigau, Anne W.M. Lee, Steffen Löck, Birgitte V. Offersen, Jens Overgaard, David I. Thwaites, Albert J. van der Kogel, Uulke A. van der Heide, Vincenzo Valentini Radiotherapy and Oncology, 2023
Roadmap for precision preclinical x-ray radiation studies Frank Verhaegen, Karl T Butterworth, Anthony J Chalmers, Rob P Coppes, Dirk de Ruysscher, Sophie Dobiasch, John D Fenwick, Patrick V Granton, Stefan H J Heijmans, Mark A Hill, Constantinos Koumenis, Kirsten Lauber, Brian Marples, Katia Parodi, Lucas C G G Persoon, Nick Staut, Anna Subiel, Rianne D W Vaes, Stefan van Hoof, Ioannis L Verginadis, Jan J Wilkens, Kaye J Williams, George D Wilson, Ludwig J Dubois Physics in Medicine and Biology, 2023
Organoids as a model to study intestinal and liver dysfunction in severe malnutrition José M. Horcas-Nieto, Christian J. Versloot, Miriam Langelaar-Makkinje, Albert Gerding, Tjasso Blokzijl, Mirjam H. Koster, Mirjam Baanstra, Ingrid A. Martini, Robert P. Coppes, Céline Bourdon, Sven C.D. van Ijzendoorn, Peter Kim, Robert H.J. Bandsma, Barbara M. Bakker Biochimica Et Biophysica Acta Molecular Basis of Disease, 2023
The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice Birgitte Vrou Offersen, Marianne C. Aznar, Carol Bacchus, Rob P. Coppes, Eric Deutsch, Dieter Georg, Karin Haustermans, Peter Hoskin, Mechthild Krause, Eric F. Lartigau, Anne W.M. Lee, Steffen Löck, David I. Thwaites, Albert J. van der Kogel, Uulke van der Heide, Vincenzo Valentini, Jens Overgaard, Michael Baumann Radiotherapy and Oncology, 2023
In Reply to Kashid et al. Roel J.H.M. Steenbakkers, Maria I. van Rijn-Dekker, Monique A. Stokman, Arjen van der Schaaf, Johanna G.M. van den Hoek, Hendrik P. Bijl, Maria C.A. Kramer, Johannes A. Langendijk, Peter van Luijk, Roel G.J. Kierkels, Rob P. Coppes International Journal of Radiation Oncology Biology Physics, 2022
In Reply to Sari and Yazici R. Steenbakkers, Maria I. van Rijn-Dekker, M. Stokman, R. Kierkels, A. van der Schaaf, J. G. van den Hoek, H. Bijl, Maria C.A. Kramer, R. Coppes, J. Langendijk, P. van Luijk International Journal of Radiation Oncology Biology Physics, 2022
Radiation oncology in the new virtual and digital era Marianne C. Aznar, Carol Bacchus, Rob P. Coppes, Eric Deutsch, Dietmar Georg, Karin Haustermans, Peter Hoskin, Mechthild Krause, Eric F. Lartigau, Steffen Löck, Birgitte Offersen, Jens Overgaard, David I. Thwaites, Albert J. van der Kogel, Uulke A. van der Heide, Vincenzo Valentini, Michael Baumann Radiotherapy and Oncology, 2021
Salivary Gland Stem Cells Age Prematurely in Primary Sjögren's Syndrome Sarah Pringle, Xiaoyan Wang, Gwenny M. P. J. Verstappen, Janneke H. Terpstra, Clarence K. Zhang, Aiqing He, Vishal Patel, Rhiannon E. Jones, Duncan M. Baird, Fred K. L. Spijkervet, Arjan Vissink, Hendrika Bootsma, Robert P. Coppes, Frans G. M. Kroese Arthritis and Rheumatology, 2019
ACE inhibition attenuates radiation-induced cardiopulmonary damage Sonja J. van der Veen, Ghazaleh Ghobadi, Rudolf A. de Boer, Hette Faber, Megan V. Cannon, Peter W. Nagle, Sytze Brandenburg, Johannes A. Langendijk, Peter van Luijk, Robert P. Coppes Radiotherapy and Oncology, 2015
Physiological interaction of heart and lung in thoracic irradiation Ghazaleh Ghobadi, Sonja van der Veen, Beatrijs Bartelds, Rudolf A. de Boer, Michael G. Dickinson, Johan R. de Jong, Hette Faber, Maarten Niemantsverdriet, Sytze Brandenburg, Rolf M.F. Berger, Johannes A. Langendijk, Robert P. Coppes, Peter van Luijk International Journal of Radiation Oncology Biology Physics, 2012
Quantifying Local Radiation-Induced Lung Damage From Computed Tomography Ghazaleh Ghobadi, Laurens E. Hogeweg, Hette Faber, Wim G.J. Tukker, Jacobus M. Schippers, Sytze Brandenburg, Johannes A. Langendijk, Robert P. Coppes, Peter van Luijk International Journal of Radiation Oncology Biology Physics, 2010
The Impact of Heart Irradiation on Dose-Volume Effects in the Rat Lung Peter van Luijk, Hette Faber, Harm Meertens, Jacobus M. Schippers, Johannes A. Langendijk, Sytze Brandenburg, Harm H. Kampinga, Robert P. Coppes International Journal of Radiation Oncology Biology Physics, 2007
Hyaluronic Acid‐silk Fibroin Hydrogel for Salivary Gland Tissue Engineering M Hajiabbas, C Pelissari, D Parisis, T Putz, C D'Agostino, M Baanstra, ... Advanced Healthcare Materials, e71225 , 2026 2026
Radiation-induced interferon-I response impairs thyroid organoid function R Maturi, D Cinat, AL Jellema-de Bruin, G De Vita, S Kruijff, RP Coppes, ... Radiotherapy and Oncology, 111453 , 2026 2026
Development of a national indication protocol for proton therapy in patients with seminoma testis to reduce the risk on subsequent primary cancers N Kuijsters, P Sinnige, PA Bakker, S Al Uwini, CL Brouwer, T Budiharto, ... International Journal of Radiation Oncology* Biology* Physics , 2026 2026
lncRNAs: a new generation of targets and biomarkers in thyroid cancer R Maturi, M Esposito, RP Coppes, G De Vita European Thyroid Journal 15 (1) , 2026 2026
Brain irradiation drives remote liver changes via senescence-independent mechanisms Y Jiang, DC Voshart, A Gustinelli, AC Scholma, E Hageman, LR Nazario, ... Radiotherapy and Oncology, 111373 , 2026 2026
Differential synaptic signaling responses in human cortical organoids after photon and proton irradiation Y Jiang, DB Guerra, DC Voshart, E Hageman, LR Nazario, ... Stem Cell Reports , 2026 2026 Citations: 1
A MONTE CARLO FRAMEWORK FOR ROBUST PROTON CONFORMAL FLASH IRRADIATION OF ECTOPIC MAMMARY TUMORS IN MICE R De Koster, J Gunawan, L Barazzuol, MJ Van Goethem, R Coppes, ... International Journal of Particle Therapy 17, 101048 , 2025 2025
IFN-I signaling enhances salivary gland stem and progenitor cell activity after irradiation D Cinat, R Van Der Wal, M Baanstra, A Soto-Gamez, R Maturi, ... Science signaling 18 (913), eady0398 , 2025 2025 Citations: 6
Notch signaling is a driver of glandular stem cell activity and regenerative migration after damage D Cinat, R Maturi, JP Gunawan, AL Jellema-de Bruin, L Kracht, ... The EMBO Journal 45 (2), 374 , 2025 2025 Citations: 3
Patient-derived medullary thyroid cancer organoids: a potential model for mechanistic studies on diagnostics and therapy EC Jager, LHJ Sondorp, R Maturi, IF Antunes, BM van Hemel, U Brouwer, ... European Thyroid Journal 14 (5) , 2025 2025 Citations: 3
Role of Klhl14 in senescence and epithelial-to-mesenchymal transition via TGF-β modulation R Maturi, A Soto-Gamez, AL Jellema-de Bruin, M Esposito, S Kruijff, ... bioRxiv, 2025.09. 12.675818 , 2025 2025
Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer LJ Boersma, A Hessels, S Roberti, E Seravalli, N Bijker, RP Coppes, ... Radiotherapy and Oncology 210, 110998 , 2025 2025 Citations: 3
Radiation-induced lung disease P van Luijk, J Wiedemann ERS Handbook of Respiratory Medicine, 646-648 , 2025 2025
Radiation-induced lung disease RP Coppes, P van Luijk ERS Handbook of Respiratory Medicine (out of print), 369-370 , 2025 2025
Development and validation of cost-effective multi-sample hypoxia chambers for proton ultra-high dose rate organoid irradiations RJC de Koster, JP Gunawan, H Peters, J Bussink, L Barazzuol, ... Clinical and Translational Radiation Oncology 53, 100970 , 2025 2025 Citations: 1
ABS0128 GENERATION OF PLURIPOTENT STEM CELL-DERIVED SALIVARY GLAND PROGENITOR CELLS FOR TRANSPLANTATION IN SJÖGREN'S DISEASE A Soto-Gamez, JH Terpstra, C Tesa, H Bootsma, FGM Kroese, R Coppes, ... Annals of the Rheumatic Diseases 84, 2073 , 2025 2025
Sustainable radiation oncology in a world with grand environmental and societal challenges: Society Matters–A new section in the Green Journal K Tanderup, BV Offersen, D Georg, RP Coppes, P Blanchard Radiotherapy and Oncology 207, 110876 , 2025 2025 Citations: 5
Establishment of salivary tissue-organoid biorepository: characterizing salivary gland stem/progenitor cells and novel differentiation marker PSMA/FOLH1 SMM Aalam, AR Varela, A Khaderi, RJ Mondesir, DG Mun, A Ding, ... npj Regenerative Medicine 10 (1), 23 , 2025 2025 Citations: 8
3329 Combination of Captopril, Ambrisentan and Sildenafil mitigates long-term side effects of combined heart and lung irradiation J Wiedemann, U Brouwer, HHW Silljé, MG Dickinson, RP Coppes, ... Radiotherapy and Oncology 206, S3942-S3943 , 2025 2025
Clinical applications of human organoids MMA Verstegen, RP Coppes, A Beghin, P De Coppi, MFM Gerli, ... Nature medicine 31 (2), 409-421 , 2025 2025 Citations: 169
MOST CITED SCHOLAR PUBLICATIONS
Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion M Mauthe, I Orhon, C Rocchi, X Zhou, M Luhr, KJ Hijlkema, RP Coppes, ... Autophagy 14 (8), 1435-1455 , 2018 2018 Citations: 2406
Oral sequelae of head and neck radiotherapy A Vissink, J Jansma, FKL Spijkervet, FR Burlage, RP Coppes Critical Reviews in Oral Biology & Medicine 14 (3), 199-212 , 2003 2003 Citations: 1380
Rescue of salivary gland function after stem cell transplantation in irradiated glands IMA Lombaert, JF Brunsting, PK Wierenga, H Faber, MA Stokman, T Kok, ... PloS one 3 (4), e2063 , 2008 2008 Citations: 608
Prevention and treatment of the consequences of head and neck radiotherapy A Vissink, FR Burlage, FKL Spijkervet, J Jansma, RP Coppes Critical Reviews in Oral Biology & Medicine 14 (3), 213-225 , 2003 2003 Citations: 604
Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers A Vissink, JB Mitchell, BJ Baum, KH Limesand, SB Jensen, PC Fox, ... International Journal of Radiation Oncology* Biology* Physics 78 (4), 983-991 , 2010 2010 Citations: 491
On the mechanism of salivary gland radiosensitivity AWT Konings, RP Coppes, A Vissink International Journal of Radiation Oncology* Biology* Physics 62 (4), 1187-1194 , 2005 2005 Citations: 454
Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer P Van Luijk, S Pringle, JO Deasy, VV Moiseenko, H Faber, A Hovan, ... Science translational medicine 7 (305), 305ra147-305ra147 , 2015 2015 Citations: 324
Long-term in vitro expansion of salivary gland stem cells driven by Wnt signals M Maimets, C Rocchi, R Bron, S Pringle, J Kuipers, BNG Giepmans, ... Stem cell reports 6 (1), 150-162 , 2016 2016 Citations: 311
Human salivary gland stem cells functionally restore radiation damaged salivary glands S Pringle, M Maimets, M van der Zwaag, MA Stokman, D van Gosliga, ... Stem cells 34 (3), 640-652 , 2016 2016 Citations: 295
Prevention and treatment of radiotherapy‐induced side effects L Barazzuol, RP Coppes, P van Luijk Molecular oncology 14 (7), 1538-1554 , 2020 2020 Citations: 294
Parotid and submandibular/sublingual salivary flow during high dose radiotherapy FR Burlage, RP Coppes, H Meertens, MA Stokman, A Vissink Radiotherapy and Oncology 61 (3), 271-274 , 2001 2001 Citations: 276
Regeneration of irradiated salivary glands with stem cell marker expressing cells LSY Nanduri, M Maimets, SA Pringle, M van der Zwaag, RP van Os, ... Radiotherapy and oncology 99 (3), 367-372 , 2011 2011 Citations: 257
Purification and ex vivo expansion of fully functional salivary gland stem cells LSY Nanduri, M Baanstra, H Faber, C Rocchi, E Zwart, G de Haan, ... Stem cell reports 3 (6), 957-964 , 2014 2014 Citations: 236
Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation J Feng, M van der Zwaag, MA Stokman, R van Os, RP Coppes Radiotherapy and oncology 92 (3), 466-471 , 2009 2009 Citations: 229
Concise review: Adult salivary gland stem cells and a potential therapy for xerostomia S Pringle, R Van Os, RP Coppes Stem cells 31 (4), 613-619 , 2013 2013 Citations: 223
Patient-derived tumor organoids for prediction of cancer treatment response PW Nagle, JTM Plukker, CT Muijs, P van Luijk, RP Coppes Seminars in cancer biology 53, 258-264 , 2018 2018 Citations: 209
Salisphere derived c-Kit+ cell transplantation restores tissue homeostasis in irradiated salivary gland LSY Nanduri, IMA Lombaert, M van der Zwaag, H Faber, JF Brunsting, ... Radiotherapy and oncology 108 (3), 458-463 , 2013 2013 Citations: 206
Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands IMA Lombaert, PK Wierenga, T Kok, HH Kampinga, G dehaan, ... Clinical Cancer Research 12 (6), 1804-1812 , 2006 2006 Citations: 206
Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists RP Coppes, LJW Zeilstra, HH Kampinga, AWT Konings British journal of cancer 85 (7), 1055-1063 , 2001 2001 Citations: 200
Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool IMA Lombaert, JF Brunsting, PK Wierenga, HH Kampinga, G De Haan, ... Stem cells 26 (10), 2595-2601 , 2008 2008 Citations: 198